2BB score and signals
Kura Oncology, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 60 | High |
| Momentum | 33 | Weakening |
| Financial strength | 8 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 47 | Moderate |
Company facts
| Headquarters | San Diego, California, United States |
| Founded | 2014 |
| Employees | 260 |
| 52-week range | $6.24 – $12.49 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.8421 | — | $24.64M |
| 2026-08-12 | — | -0.8952 | — | $21.85M |
| 2026-05-12 | -0.83 | -0.6456 | $18.27M | $18.88M |
| 2026-03-05 | -0.92 | -0.4946 | $17.34M | $76.65M |
Related companies
2BBBullish & Bearish